Skip to content
Original
clinicaltrials.gov· Merck Sharp & Dohme LLC · ClinicalTrials.gov·· 4 hours agoPickScore35

Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)

Source: clinicaltrials.gov

#Other#Merck
CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org